20/10/2020 – AB Science announces positive top-line Phase 3 results for oral masitinib in severe asthma
AB Science
Masitinib and AB8939 – Two compounds with breakthrough mechanism of action
20/10/2020 – AB Science announces positive top-line Phase 3 results for oral masitinib in severe asthma
